Principles of geriatric pharmacotherapy
Journal Title: Postępy Nauk Medycznych - Year 2011, Vol 24, Issue 8
Abstract
Geriatrics is a part of medicine inherently linked to polysymptomathology and polypharmacology, and a rational attempt at pharmacology of the elderly is among the most important aspects of medical care. Awareness of the facts described in this article (in particular modified pharmacokinetics and pharmacodynamics, drug interactions, and drug-disease interactions) should facilitate the formulation of clear standards in pharmacotherapy of elderly, which, in turn, would help us to avoid many therapeutic failures and improve the overall life standard of the elderly population.
Authors and Affiliations
Agnieszka Borzym
Evaluation of vitamin D status in pregnant women in Warsaw – preliminary report
Introduction. Vitamin D deficiency is fairly common throughout the world, in all agegroups. Whereas, in most countries there is still no accurate data providing de tailed informationon specific populations, especially pr...
Defensin DEFB4A transcript level in the differentiation of keratoacanthoma, squamous and basal cell carcinomas
Introduction. Defensins are peptide with antimicrobial, antiviral, antifungal activities and many other functions, such as induction of immunological response and antitumor activity. Changes in expression level of defens...
Intramedullary fixation of humeral fractures and non-unions of humerus
Humeral fractures are considered as a difficult clinical problem. Such fractures had been treated non-operatively for many years and early trials with plate fixation were often followed by non-union. The creation of intr...
Comparison of two quantitative methods of microscopic feto-maternal haemorrhage evaluation
<b>Introduction.</b> Quantification of feto-maternal haemorrhage (FMH) is essential for determination of an accurate dose of anti-RhD Ig in immunoprophylaxis of haemolytic disease of foetus an...
Analiza wczesnego chimeryzmu przy użyciu PCR w czasie rzeczywistym jako czynnik rokowniczy choroby przeszczep przeciwko gospodarzowi po allogenicznym przeszczepieniu hematopoetycznych komórek krwiotwórczych
Ocena chimeryzmu dawcy odgrywa znaczącą rolę w rokowaniu pacjentów po allogenicznym przeszczepieniu hematopoetycznych komórek krwiotwórczych (alloHSCT).<br><b>Materiał i metody.</b&...